Literature DB >> 16779701

Nanotechnology: intelligent design to treat complex disease.

Patrick Couvreur1, Christine Vauthier.   

Abstract

The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the "magic bullet" proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16779701     DOI: 10.1007/s11095-006-0284-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.580


  362 in total

Review 1.  Immune effects and mechanisms of action of CpG motifs.

Authors:  A M Krieg
Journal:  Vaccine       Date:  2000-11-08       Impact factor: 3.641

2.  The early bactericidal activity of a low-clearance liposomal amikacin in pulmonary tuberculosis.

Authors:  P R Donald; F A Sirgel; A Venter; E Smit; D P Parkin; B W Van de Wal; D A Mitchison
Journal:  J Antimicrob Chemother       Date:  2001-12       Impact factor: 5.790

Review 3.  New technology platforms in the development of vaccines for the future.

Authors:  R Glück; I C Metcalfe
Journal:  Vaccine       Date:  2002-12-20       Impact factor: 3.641

4.  Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.

Authors:  K E Anderson; L A Eliot; B R Stevenson; J A Rogers
Journal:  Pharm Res       Date:  2001-03       Impact factor: 4.200

5.  Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.

Authors:  Jing Wang; Bei Hu; Minchao Xu; Qun Yan; Shuangyou Liu; Xuhui Zhu; Ziyong Sun; Deding Tao; Li Ding; Eddie Reed; Jianping Gong; Qingdi Q Li; Junbo Hu
Journal:  Int J Mol Med       Date:  2006-02       Impact factor: 4.101

6.  Nanotechnology helps medicine: nanoscale swimmers and their future applications.

Authors:  Zahra Ghalanbor; Sayed-Amir Marashi; Bijan Ranjbar
Journal:  Med Hypotheses       Date:  2005       Impact factor: 1.538

Review 7.  Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review.

Authors:  H Maeda; J Wu; T Sawa; Y Matsumura; K Hori
Journal:  J Control Release       Date:  2000-03-01       Impact factor: 9.776

8.  Influence of spacer length on interaction of mannosylated liposomes with human phagocytic cells.

Authors:  Andreas Engel; Swapan Kumar Chatterjee; Ali Al-arifi; Dagmar Riemann; Jürgen Langner; Peter Nuhn
Journal:  Pharm Res       Date:  2003-01       Impact factor: 4.200

9.  Acid-triggered release via dePEGylation of DOPE liposomes containing acid-labile vinyl ether PEG-lipids.

Authors:  Junhwa Shin; Pochi Shum; David H Thompson
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

Review 10.  Development of liposomal polyene antibiotics: an historical perspective.

Authors:  Agatha W K Ng; Kishor M Wasan; Gabriel Lopez-Berestein
Journal:  J Pharm Pharm Sci       Date:  2003 Jan-Apr       Impact factor: 2.327

View more
  102 in total

1.  Raman microscopy for noninvasive imaging of pharmaceutical nanocarriers: intracellular distribution of cationic liposomes of different composition.

Authors:  T Chernenko; R R Sawant; M Miljkovic; L Quintero; M Diem; V Torchilin
Journal:  Mol Pharm       Date:  2012-03-15       Impact factor: 4.939

Review 2.  Development and applications of photo-triggered theranostic agents.

Authors:  Prakash Rai; Srivalleesha Mallidi; Xiang Zheng; Ramtin Rahmanzadeh; Youssef Mir; Stefan Elrington; Ahmat Khurshid; Tayyaba Hasan
Journal:  Adv Drug Deliv Rev       Date:  2010-09-19       Impact factor: 15.470

3.  Biological activity of anti-CD20 multivalent HPMA copolymer-Fab' conjugates.

Authors:  Russell N Johnson; Pavla Kopečková; Jindřich Kopeček
Journal:  Biomacromolecules       Date:  2012-02-21       Impact factor: 6.988

Review 4.  Polymeric nanogel formulations of nucleoside analogs.

Authors:  Serguei V Vinogradov
Journal:  Expert Opin Drug Deliv       Date:  2007-01       Impact factor: 6.648

5.  Low-temperature 1H-NMR spectroscopic study of doxorubicin influence on the hydrated properties of nanosilica modified by DNA.

Authors:  V V Turov; V F Chehun; V N Barvinchenko; T V Krupskaya; Yu I Prylutskyy; P Scharff; U Ritter
Journal:  J Mater Sci Mater Med       Date:  2011-02-02       Impact factor: 3.896

6.  Tracking of multimodal therapeutic nanocomplexes targeting breast cancer in vivo.

Authors:  Rizia Bardhan; Wenxue Chen; Marc Bartels; Carlos Perez-Torres; Maria F Botero; Robin Ward McAninch; Alejandro Contreras; Rachel Schiff; Robia G Pautler; Naomi J Halas; Amit Joshi
Journal:  Nano Lett       Date:  2010-11-22       Impact factor: 11.189

7.  Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers.

Authors:  Renee R Hood; Chenren Shao; Donna M Omiatek; Wyatt N Vreeland; Don L DeVoe
Journal:  Pharm Res       Date:  2013-02-06       Impact factor: 4.200

8.  Morphological Modification of Carbon Nanoparticles after Interacting with Methotrexate as a Potential Anticancer Agent.

Authors:  Muthukumar Thangavelu; Aravinthan Adithan; Sastry Thotapalli Parvathaleswara; Chamundeeswari Munusamy
Journal:  Pharm Res       Date:  2018-08-02       Impact factor: 4.200

Review 9.  Crucial functionalizations of carbon nanotubes for improved drug delivery: a valuable option?

Authors:  Giorgia Pastorin
Journal:  Pharm Res       Date:  2009-01-14       Impact factor: 4.200

10.  Transport and delivery of interferon-α through epithelial tight junctions via pH-responsive poly(methacrylic acid-grafted-ethylene glycol) nanoparticles.

Authors:  Mary Caldorera-Moore; Julia E Vela Ramirez; Nicholas A Peppas
Journal:  J Drug Target       Date:  2019-03-01       Impact factor: 5.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.